By Joe Hoppe Shield Therapeutics said Chief Financial Officer Hans-Peter Rudolf will step down from the role on Oct. 20 to pursue other opportunities, and.
By Elena Vardon Shield Therapeutics shares fell on Thursday after the company said it intends to raise up to $27.4 million through a debt facility and.
By Joe Hoppe Shield Therapeutics shares rose Thursday after the company said U.S. prescriptions for its Accrufer product for iron deficiency rose 50% on.